As you grow older, age-related stiffness and discomfort in the joints becomes a fact of life. Activities once routine become a challenge as limited mobility hampers your every move.
You now have a more potent option to provide broad-spectrum support for aging joints. ArthroMax® Advanced with UC-II® and AprèsFlex® is a multi-nutrient formula based on the very latest data on natural support for joint health. This ArthroMax™ formula provides more joint support with two innovative, clinically validated ingredients: AprèsFlex® and UC-II®.
AprèsFlex® represents a quantum leap forward in the delivery of boswellia to aging joints. Long prized for its ability to help inhibit inflammatory factors, boswellia is especially effective at inhibiting the 5-LOX (5-lipoxygenase) enzyme.
Excess activity of 5-LOX results in the accumulation of leukotriene B4, a pro-inflammatory compound that affects aging joints. Boswellia has been shown to bind directly to the 5-LOX enzyme, preventing it from facilitating production of pro-inflammatory leukotrienes.69,70
AprèsFlex® boswellia absorbs into the blood 52% better than previously available forms of boswellia, for superior effectiveness.71
In addition to AprèsFlex®, this ArthroMax® formulation contains a standardized chicken cartilage called UC-II®. Data shows it supports immune health, joint comfort and ease of motion in aging individuals.
Serving Size 2 capsules
Servings Per Container 30
Glucosamine sulfate 2KCI (derived from corn)
AprèsFlex® Indian frankincense (Boswellia serrata) extract (gum resin) [std. to 20% AKBA? (20 mg)]
UC-II® standardized cartilage
Boron (calcium fructoborate as patented FruiteX B® OsteoBoron®)
Other ingredients: vegetable cellulose (capsule), potassium chloride, microcrystalline cellulose, vegetable stearate, silica.
UC-II® is a registered trademark of InterHealth N.I. (U.S. Patents 7,846,487, 7,083,820 and EPO Patent EP1435906B1; Canadian Patent CA 2459981C; and Japanese Patent JP 4800574B2).AprèsFlex® is a registered trademark of Laila Nutraceuticals exclusively licensed to PL Thomas - Laila NUTRA LLC. U.S. Patent No. 8,551,496 and other patents pending.FruitX B® and OsteoBoron® are registered trademarks of VDF FutureCeuticals, Inc. U.S. Patent No. 5,962,049.